Mark R. Gilbert

Computational modeling demonstrates that glioblastoma cells can survive spatial environmental challenges through exploratory adaptation

Orieta Celiku, Mark R. Gilbert, Orit Lavi, 2019, Nature Communications.

LONGITUDINAL MOLECULAR TRAJECTORIES OF DIFFUSE GLIOMA IN ADULTS

Colin Watts, Marion Smits, Andrew E. Sloan, 2019, Nature.

QLIF-17. THE IMPORTANCE OF THE CERN FOUNDATION ADULT EPENDYMOMA OUTCOMES PROJECT

Mark R. Gilbert, Alvina Acquaye, Elizabeth Vera, 2016 .

Predictors of Survival among Pediatric and Adult Ependymoma Cases: A Study Using Surveillance, Epidemiology, and End Results Data from 1973 to 2007

Mark R. Gilbert, E. Susan Amirian, Terri S. Armstrong, 2012, Neuroepidemiology.

Validation and Development of a Modified Breast Graded Prognostic Assessment As a Tool for Survival in Patients With Breast Cancer and Brain Metastases.

Jeffrey S. Weinberg, Ankur Varma, Mark R. Gilbert, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Standardized Brain Tumor Imaging Protocol for Clinical Trials

Daniel P. Barboriak, Jerrold L. Boxerman, Mark R. Gilbert, 2015, American Journal of Neuroradiology.

NIMG-56IMMUNOTHERAPY RESPONSE ASSESSMENT IN NEURO-ONCOLOGY (iRANO): A REPORT OF THE RANO WORKING GROUP

Naoya Hashimoto, Enrico Franceschi, Ashok Panigrahy, 2015 .

Differentiating pseudoprogression from true progression: analysis of radiographic, biologic, and clinical clues in GBM

John A. Butman, Holly Ning, Kevin Camphausen, 2018, Journal of Neuro-Oncology.

Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma.

Walter J. Curran, Mark R. Gilbert, Jean-Paul Bahary, 2016, The New England journal of medicine.

Challenges to curing primary brain tumours

Giles W. Robinson, Paul Workman, Amar Gajjar, 2019, Nature Reviews Clinical Oncology.

Phase I three-dimensional conformal radiation dose escalation study in newly diagnosed glioblastoma: Radiation Therapy Oncology Group Trial 98-03.

James A. Purdy, Jeff M. Michalski, Walter J. Curran, 2009, International journal of radiation oncology, biology, physics.

Erratum: MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma (Neuro-Oncology (2010) 12:2 (116-121))

Mark R. Gilbert, Howard Colman, K. Aldape, 2010 .